ALPN

Alpine Immune Sciences, Inc. Common Stock
ALPN

Overview Fund Activity
Delisted

ALPN was delisted on the 17th of May, 2024.

Back to rankings

50 hedge funds and large institutions have $100M invested in Alpine Immune Sciences, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 4 closing their positions.

Holders
50
Holders Change
+3
Holders Change %
+6.38%
% of All Funds
1.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
11
Reduced
15
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SFM
1
Sphera Funds Management
Israel
$1.66M
2
Axa
2
Axa
France
$5.3M
3
EAM
3
EverPoint Asset Management
Connecticut
$1.79M
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$1.04M
5
O
5
OrbiMed
New York
$480K

Top Sellers

1
SM
1
Sabby Management
Florida
$2.18M
2
BI
2
BVF Inc
California
$13.9M
3
Jennison Associates
3
Jennison Associates
New York
$2.67M
4
AC
4
Ascend Capital
California
$0
5
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$161K
Name Market Value Shares Shares
Change 		Shares
Change %
AC
51
Ascend Capital
California
– – -150,000 Closed
PP
52
Paloma Partners
Connecticut
– – -22,681 Closed
EA
53
Emerald Acquisition
Washington
– – -15,339 Closed
TRCT
54
Tower Research Capital (TRC)
New York
– – -2,505 Closed
1 2
3